Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Idioma
Intervalo de año de publicación
1.
Artículo en Ruso | MEDLINE | ID: mdl-34719906

RESUMEN

Hyperbaric oxygenation (HBO) for correction of platelet haemostasis disorders in coronary heart disease (CHD) is reasonable due to the associated hypocoagulation. However, in practice, the baseline state of platelet activity is not considered when prescribing HBO therapy. Available publications lack information on structural changes in the platelet membrane associated with the of phospholipase A2 (PLA2) activity, and on the HBO effect on the various steps of hemostasis. OBJECTIVE: To study changes in serum PLA2 concentration and its relation to platelet aggregation activity during HBO in patients with stable CHD. MATERIAL AND METHODS: We examined 42 patients with stable angina FC II-III, 27 received antiplatelet therapy (Cardiomagnyl 75 mg: acetylsalicylic acid + magnesium hydroxide), and 15 patients did not. All patients received a 10-day course of HBO at 1.2 atmosphere mode for 40 min. Platelet hemostasis and serum PLA2 concentration were evaluated. Platelet aggregation was tested using Biola LA-230-2 aggregation analyzer (Biola Scientific, Russia). The platelets count and mean platelet volume (MPV) were determined on a Mindray BS-3200 hematology analyzer (Mindray, China). PLA2 levels were determined by enzyme immunoassay using Model 680 microplate reader (Bio-Rad, USA). Residual platelet reactivity was evaluated by 5.0 ADP-induced aggregation. RESULTS: Assessment of the HBO effect on the functional state of platelets depending on their aggregation activity and the therapy taken showed a significant increase in spontaneous aggregation and ADP-induced aggregation at inducer concentration of 1.0 µM (p=0.049) in patients with baseline hyperaggregation taking Cardiomagnyl after HBO. No significant changes in PLA2 concentration were observed. At the same time, patients with baseline hyperaggregation who did not take antiplatelet agents had no changes in platelet aggregation activity and a decreased serum PLA2. In patients with baseline normal aggregation receiving an antiplatelet drug, a course of HBO had no effect on platelet aggregation activity and PLA2 level. In patients with baseline normal aggregation who did not take antiplatelet agents, a course of HBO resulted in significant decrease in PLA2 levels and no changes in platelet aggregation activity. In patients with low aggregation activity (hypoaggregation) who took antiplatelet agents, a significant increase in spontaneous aggregation and no change of serum PLA2 after an HBO course was observed. CONCLUSION: The study showed a divergent response to the hyperbaric oxygen, depending on the antiplatelet therapy and the background aggregation.


Asunto(s)
Oxigenoterapia Hiperbárica , Isquemia Miocárdica , Humanos , Isquemia Miocárdica/terapia , Fosfolipasas A2/farmacología , Agregación Plaquetaria , Inhibidores de Agregación Plaquetaria/farmacología
2.
Artículo en Ruso | MEDLINE | ID: mdl-30168508

RESUMEN

BACKGROUND: The authors present evidence of the significance and role of the disturbances in platelet hemostasis in pathogenesis of co-morbid cardiac pathology and the absence of the unambiguous opinion as regards the expediency of the application of hyperbaric oxygenation (HBO) for their correction which implies the necessity of searching for new pathogenetically substantiated approaches to the treatment of the patients presenting with this condition. AIM: The objective of the present study was to evaluate the influence of hyperbaric oxygenation on the elastic properties of platelet membrane during spontaneous platelet aggregation in the patients presenting with cardiac co-morbidity. MATERIAL AND METHODS: Thrombocyte hemostasis was investigated in 24 patients at the age of 52.9±11.5 years (67% of men, 33% of women) presenting with functional class II angina of effort concomitant with arterial hypertension (AH). All the patients were given, in addition to the conventional treatment of the main diseases, the courses of daily (No. 5) 30-minute sessions of hyperbaric oxygenation in the 1,2ATA regime in the BLKS 301M and 303MK barochambers (Russia). Before and after HBO, spontaneous aggregation of thrombocytes (light agglomeration method) was determined with the use of a two-channel Biol LA-230-2 laser analyzer (Russia). The elastic properties of the platelet cell membrane were elucidated by atomic-force microscopy in the contact mode using the cantilever type PNP-DB on the Solver P47-PRO scanning probe microscope (Nt-MDT, Russia). RESULTS: The co-morbid cardiac pathology was accompanied by hyperaggregation and hypoaggregation of the platelets (33.3% and 25% respectively). The high levels of spontaneous aggregation in men (1.46±0.47) and the dependence of platelet plate stiffness on the aggregation state were documented. HBO sessions were accompanied by a reduction of spontaneous platelet aggregation in men (0.84±0.19) and a two-fold decrease in the modulus of elasticity in comparison with its initial value in the patients with platelet hyperaggregation (0.42±0.16, p<0.05). CONCLUSION: The membrane-modifying effect of HBO on the platelets is characterized by an increase in the elasticity of their membranes concurrent with a reduction of spontaneous aggregation of platelets, predominantly in men.


Asunto(s)
Enfermedades Cardiovasculares/terapia , Oxigenoterapia Hiperbárica , Agregación Plaquetaria/fisiología , Adulto , Enfermedades Cardiovasculares/epidemiología , Comorbilidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Federación de Rusia
3.
Artículo en Ruso | MEDLINE | ID: mdl-29053121

RESUMEN

AIM: To study the efficacy of a current regimen of treatment with cavinton for infusions and cavinton comforte in patients with ischemic stroke in acute and early recovery periods and to evaluate an impact of treatment on erythrocyte deformity using atomic power microscopy. MATERIAL AND METHODS: One hundred and sixty-four patients with hemispheric ischemic stroke, aged from 30 to 79 years, were randomized into main (n=100) and control (n=64) groups. Patients of the main group received complex treatment (basic therapy and cavinton R for drop infusions (10 intravenously during 10 days) followed by cavinton R comforte in dose 10 mg, 1 tablet 3 times a day during 90 days). Patients of the control group received basic therapy only. NIHSS, the Rankin scale, the Barthel index, MMSE, MоCA, the Rivermead scale, Beck depression scale, HADS were used to measure the severity of patient's state. To study the erythrocyte membrane by estimating Young's modulus, dry preparations were made with the following scanning of erythrocytes using atomic power microscopy. RESULTS: Positive changes on all scales were observed in both groups. Higher scores on NIHSS, Rankin, Barthel, MоCA, MMSE, Rivermead mobility index were found in the main group compared to the controls. There were no differences in scores on the Beck depression scale and HADS. A decrease in Young's modulus was found in the main group while in the control group this index remained unchanged. CONCLUSION: More rapid and complete regression of neurological deficit, better recovery of self-care function, cognitive function and social activity, an increase in erythrocyte membrane elasticity were found in the main group compared to the control one. These results indicate the efficacy of cavinton R and cavinton R comforte in the regimen used in complex treatment in acute and early recovery periods after ischemic stroke.


Asunto(s)
Isquemia Encefálica/complicaciones , Accidente Cerebrovascular/tratamiento farmacológico , Accidente Cerebrovascular/etiología , Alcaloides de la Vinca/uso terapéutico , Adulto , Anciano , Cognición , Quimioterapia Combinada , Módulo de Elasticidad , Membrana Eritrocítica , Femenino , Humanos , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Alcaloides de la Vinca/administración & dosificación
4.
Artículo en Ruso | MEDLINE | ID: mdl-26120988

RESUMEN

OBJECTIVE: To study the effect of vasonit on the structural/functional state of erythrocyte cytoplasmic membrane in patients with ischemic stroke (11) using atomic-power microscopy in vitro. MATERIAL AND METHODS: We examined 45 patients with II. Patients of the main group (n=30) received vasonit and standard treatment, 15 patients of the comparison group received only standard treatment. To assess the severity of patient's condition, we used the NIH stroke scale, modified Rankin scale, the Barthel index and the Rivermead Mobility index. Dried erythrocyte preparations were made to study erythrocyte cytoplasmic membrane. Scanning was performed using an atomic-power microscope manufactured by "SOLVER P47-Pro" (NT-MDT, Russia). RESULTS AND CONCLUSION: A statistically significant positive dynamics of neurological deficit and patient's functional state was found in the 14" day of the study. A significant decrease in Young's modulus value was identified in the main group that suggested the increase in the elasticity of erythrocyte cytoplasmic membrane.


Asunto(s)
Agonistas alfa-Adrenérgicos/uso terapéutico , Membrana Eritrocítica/efectos de los fármacos , Nafazolina/uso terapéutico , Accidente Cerebrovascular/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Isquemia Encefálica/complicaciones , Módulo de Elasticidad/efectos de los fármacos , Membrana Eritrocítica/patología , Femenino , Humanos , Masculino , Microscopía de Fuerza Atómica , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Accidente Cerebrovascular/etiología , Accidente Cerebrovascular/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...